CanRisk-Based Ovarian Cancer Risk Assessment Versus Standard Practice (DISARM CSA)

The purpose of this study is to improve how the risk of developing ovarian cancer is assessed in people who may be at increased risk of ovarian cancer due to their family history or genetic background. In current clinical practice, ovarian cancer risk assessment usually relies on information about cancer in the family and, in some cases, genetic testing for certain genes known to be associated with ovarian cancer. While this approach is commonly used, the inclusion of additional factors may support more personalised ovarian cancer risk assessment. This study compares two approaches to ovaria

Trial Details

NCT ID
NCT07809659
Phase
NA
Sponsor
Instituto Portugues Oncologia de Lisboa Francisco Gentil
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • CanRisk
  • Standard clinical risk assessment
Locations (sample)
  • Prague, Czechia|50.08804,14.42076
  • Prague, Czechia|50.08804,14.42076
  • Athens, Attica, Greece|37.98376,23.72784
  • Athens, Greece|37.98376,23.72784
  • Kaunas, Lithuania|54.90156,23.90909

Key Eligibility Criteria

  • Women, trans men, non-binary people with female reproductive organs
  • Aged 18 to 75 years
  • Referred or self-referred because of a family history suggestive of increased risk for ovarian, fallopian tube or peritoneum cancer, or because a f…
  • Able to give informed consent

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →